SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Essential medicines for universal health coverage · Study

ReviewEssential medicines for universal health coverage

Veronika J. Wirtz2016

OA

Reviewbronze2016

Essential medicines for universal health coverage

Veronika J. Wirtz · Hans V. Hogerzeil · Maryam Bigdeli · Cornelis de Joncheere · Margaret A Ewen · Martha Gyansa‐Lutterodt +14 more

661 citations·0/0 files stored·The Lancet

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Healthcare Systems and Reforms Pharmaceutical Quality and Counterfeiting

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 661 citations exist upstream.

References

2008Cochrane Handbook for Systematic Reviews of Interventions 2010Cochrane Handbook for Systematic Reviews of Interventions 2003The price of innovation: new estimates of drug development costs 2016Innovation in the pharmaceutical industry: New estimates of R&D costs 1949World Health Statistics 2010Health systems financing and the path to universal coverage 2013Global health 2035: a world converging within a generation 2013Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force

Cited by

2018Health systems development in Thailand: a solid platform for successful implementation of universal health coverage 2017Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending 2017The path to longer and healthier lives for all Africans by 2030: the Lancet Commission on the future of health in sub-Saharan Africa 2020Enhancing global access to cancer medicines 2017How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2017Economic Burden of Chronic Ill Health and Injuries for Households in Low- and Middle-Income Countrieschapter · 4 shared references 2016The High Cost of Prescription Drugs in the United Statesarticle · 3 shared references 2017Financing transformative health systems towards achievement of the health Sustainable Development Goals: a model for projected resource needs in 67 low-income and middle-income countriesarticle · 3 shared references 2021How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessmentreview · 3 shared references 2019The legal determinants of health: harnessing the power of law for global health and sustainable developmentreview · 3 shared references 2018Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation studyarticle · 3 shared references

Details

Year2016

Typereview

Published2016-11-07

VenueThe Lancet

ISSN-L0099-5355

Languageen

Citations661

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.1016/s0140-6736(16)31599-9

openalex_workW2554416008

Links

Imported from OpenAlex (CC0) — nothing here is generated.

2021Psychotropic medicine consumption in 65 countries and regions, 2008–19: a longitudinal study

2023Challenges to the Availability and Affordability of Essential Medicines in African Countries: A Scoping Review

2019The costs of diabetes treatment in low- and middle-income countries: a systematic review